TABLE 1.

Demographics for of PD patients and healthy controls.

	Control group (n = 22)	PD group (n = 23)	P-value
Sex, male/female	14/8	15/8	0.912
Age, years	63.64 ± 6.89	65.65 ± 8.39	0.384
Disease duration, years	NA	5.49 ± 3.86	NA
UPDRS-III motor score	NA	21.74 ± 6.74	NA
H&Y stage	NA	2.11 ± 0.66	NA
MoCA	NA	24.57 ± 2.51	NA
LEDD	NA	559.40 ± 263.70	NA

Age, disease duration, UPDRS-III motor score and H&Y stage represent by mean ± SD. P-value is based on the Chi-square test for gender and the independent samples t-test for age. MoCA, montreal cognitive assessment; LEDD: levodopa equivalent daily dose; NA, not applicable.